Clinical Trials Browser

Phase 3 × Has results × Vomiting × Clear all

NCT00343460 2026-03-02

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Phase 3 Completed

1,428 enrolled 21 charts

Nausea, Vomiting

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Phase 3 Completed

401 enrolled 14 charts

Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell

NCT01363479 2021-09-22

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

743 enrolled 10 charts

Vomiting

NCT01536392 2021-06-11

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

Phase 3 Completed

76 enrolled 8 charts

Uterine Cervical Neoplasms, Nausea, Vomiting

NCT00553059 2020-10-09

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

Phase 3 Completed

62 enrolled 15 charts

Nausea, Vomiting

NCT03403712 2020-06-01

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Phase 3 Completed

404 enrolled 19 charts

Vomiting

NCT00206440 2018-12-06

NEXIUM

Phase 3 Terminated

43 enrolled 5 charts

Breast Neoplasms, Nausea, Vomiting

NCT02557035 2018-06-20

An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting

Phase 3 Completed

441 enrolled 20 charts

Vomiting

NCT00601172 2018-01-17

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase 3 Completed

710 enrolled 29 charts

Gastrointestinal

Nausea, Vomiting, Colorectal Neoplasms

NCT00880191 2016-07-06

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Phase 3 Completed

430 enrolled 11 charts

Nausea, Vomiting

NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Phase 3 Completed

1,021 enrolled 10 charts

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT01132547 2015-07-02

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Phase 3 Terminated

22 enrolled 9 charts

CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Body Weight Changes, Bone Neoplasms, Cachexia, Chondrosarcoma, Fibrosarcoma, Glioblastoma, Hemangiosarcoma, Liposarcoma, Medulloblastoma, Nausea, Neoplasms, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Sarcoma, Sarcoma, Ewing, Mast-Cell Sarcoma, Osteosarcoma, Testicular Neoplasms, Vomiting, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Hepatoblastoma, Sarcoma, Endometrial Stromal, Neuroectodermal Tumors, Primitive, Peripheral, Neoplasms, Neuroepithelial, Optic Nerve Glioma

NCT01339260 2014-11-26

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Phase 3 Completed

1,455 enrolled 11 charts

Vomiting